Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Ibezapolstat by Acurx Pharmaceuticals for Clostridioides difficile Infections (Clostridium difficile Associated Disease): Likelihood of Approval
Ibezapolstat is under clinical development by Acurx Pharmaceuticals and currently in Phase II for Clostridioides difficile Infections (Clostridium difficile Associated...
Data Insights
Risk adjusted net present value: What is the current valuation of Acurx Pharmaceuticals's Ibezapolstat?
Ibezapolstat is a small molecule commercialized by Acurx Pharmaceuticals, with a leading Phase II program in Clostridioides difficile Infections (Clostridium...